Treatment of impending tumor lysis with single-dose rasburicase.
about
Urate oxidase for the prevention and treatment of tumour lysis syndrome in children with cancerUrate oxidase for the prevention and treatment of tumor lysis syndrome in children with cancerRecognizing and managing the expanded risk of tumor lysis syndrome in hematologic and solid malignanciesTumor lysis syndrome: new challenges and recent advances.A randomized trial of a single-dose rasburicase versus five-daily doses in patients at risk for tumor lysis syndrome.Emerging role of rasburicase in the management of increased plasma uric acid levels in patients with hematologic malignancies.Reduced-dose rasburicase in the treatment of adults with hyperuricemia associated with malignancy.Treatment of Burkitt lymphoma in adults.Reduced-dose rasburicase (recombinant xanthine oxidase) in adult cancer patients with hyperuricemia.Pitfalls in predicting tumor lysis syndrome.Clarifying the role of rasburicase in tumor lysis syndrome.One for the road! A study to assess the efficacy of single low-dose regimen of rasburicase in controlling hyperuricaemia in patients with tumour lysis syndrome due to haematological malignancies.Prevention and treatment of tumor lysis syndrome, and the efficacy and role of rasburicase.Rasburicase for the prevention and treatment of hyperuricemia in tumor lysis syndrome.A review of tumour lysis syndrome with targeted therapies and the role of rasburicase.Urate oxidase for the prevention and treatment of tumour lysis syndrome in children with cancer.Single dose rasburicase in the management of tumor lysis syndrome in childhood acute lymphoblastic leukemia: A case series.Use of single-dose rasburicase in an obese female.Evaluation of a single fixed dose of rasburicase 7.5 mg for the treatment of hyperuricemia in adults with cancer.Recurrent chemotherapy-induced tumor lysis syndrome (TLS) with renal failure in a patient with chronic lymphocytic leukemia - successful treatment and prevention of TLS with low-dose rasburicase.Effective treatment and prophylaxis of hyperuricemia and impaired renal function in tumor lysis syndrome with low doses of rasburicase.Recombinant urate oxidase (rasburicase) for the prevention and treatment of tumor lysis syndrome in patients with hematologic malignancies.Treatment of tumor lysis syndrome in children with leukemia/lymphoma in resource-limited settings-Efficacy of a fixed low-dose rasburicase.
P2860
Q24194387-D52E4A5C-2CD6-4F02-91A6-71C1BB2E67FAQ24234902-675C0667-3631-430D-A8F2-9B6D4A3BE497Q26862904-796999A0-9E9E-46F2-B839-CB545DECF5BFQ33595615-D65B33ED-5317-4BB7-AEF6-AA6FEA868D87Q33947841-7CAA8535-8FAE-4212-A944-875EE2831C9FQ35683889-CF801DBA-1790-4F70-9757-F37016F843F4Q36390913-E70F3CA7-360A-4FDF-9EDA-67D2A21765E2Q36407453-10ABA529-AC8D-4201-B545-7FC601F33F24Q36481536-37CABABF-C333-4B7E-80C3-5115EAC3B7EAQ36497392-13DCB821-B13D-4821-BAFD-671B22FD2460Q36693863-092AF8E7-5952-4B65-8753-9D8BD80C207CQ37372898-8792C9AF-4728-4788-AA15-C7F1C17F1BF4Q37629599-32102964-60A9-46A2-BBA8-0D3900958D69Q37634744-87A87437-9D0A-4E33-BED5-383406E82441Q37866341-4E3A574F-99B1-4D7A-B4B3-64B92F5286C9Q38921102-C30EC7B1-AEB5-4EED-BD1F-6CB91EE02B37Q41119377-2003AE60-AC45-4D61-9223-BCFA9BD90E78Q45006199-CA6613BF-5ABD-4CF4-AD76-96744B2517BFQ46575274-C6F1BC56-7A7C-45A2-BBDB-1D9D43A7E5A8Q46824175-48ECD027-476D-46EA-9EEC-E7F31AD87B24Q46849211-AAC04BB1-3F59-4038-B20F-59037ECEDD94Q46902520-4FBD7C26-5120-4DD4-A442-E311C4854496Q48033577-3CBB37DD-9F2D-4CE9-8303-0B6A3B85B5AC
P2860
Treatment of impending tumor lysis with single-dose rasburicase.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Treatment of impending tumor lysis with single-dose rasburicase.
@en
Treatment of impending tumor lysis with single-dose rasburicase.
@nl
type
label
Treatment of impending tumor lysis with single-dose rasburicase.
@en
Treatment of impending tumor lysis with single-dose rasburicase.
@nl
prefLabel
Treatment of impending tumor lysis with single-dose rasburicase.
@en
Treatment of impending tumor lysis with single-dose rasburicase.
@nl
P2093
P2860
P356
P1476
Treatment of impending tumor lysis with single-dose rasburicase
@en
P2093
P2860
P304
P356
10.1345/APH.1D111
P407
P577
2003-11-01T00:00:00Z